Posted by Michael Wonder on 12 Nov 2019
Three deaths following epilepsy drug brand switch
12 November 2019 - Three deaths have been reported to the Centre for Adverse Reactions Monitoring after PHARMAC forced patients using the medicine lamotrigine to switch brands.
About 11,000 people - most with epilepsy but some with mental health conditions - are switching to a generic form of the drug, called Logem.
Medsafe announced on its website today that three deaths had now been reported in relation to the switch.
